Abstract: According to various embodiments, a furniture system and method of manufacture is disclosed. The furniture system may comprise one or more raised horizontal platforms. The plurality of platforms may flank a basin, such as a catch basin. The furniture system may comprise one or more support members to support and/or raise the platforms and/or basin from ground level. The furniture system may comprise one or more containers.
Abstract: Skin lightening additives and skin lightening compositions having at least one of a heterosubstituted, saturated or unsaturated aliphatic acid are described. The compositions are suitable for topical application and comprise ricinoleic acid.
Abstract: In one aspect, the invention relates to compounds having the formula: where R1-R6, a, b, and Z are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and processes and intermediates for preparing such compounds.
Type:
Application
Filed:
August 28, 2015
Publication date:
March 17, 2016
Applicant:
THERAVANCE BIOPHARMA R&D IP, LLC
Inventors:
Adam D. Hughes, Erik Fenster, Melissa Fleury, Roland Gendron, Edmund J. Moran
Abstract: A method is provided for calculating a performance of a photovoltaic module comprising at least a first photovoltaic cell and a second photovoltaic cell. The method comprises calculating a heat flow between the first photovoltaic cell and the second photovoltaic cell using a first thermal equivalent circuit of the first photovoltaic cell and a second thermal equivalent circuit of the second photovoltaic cell, wherein at least one node of the first thermal equivalent circuit is connected to a corresponding node of the second thermal equivalent circuit by a thermal coupling resistance. The method may be used for calculating the influence of spatial and temporal variations in the operation conditions on the performance, such as the energy yield, of a photovoltaic module or a photovoltaic system.
Type:
Application
Filed:
September 16, 2015
Publication date:
March 17, 2016
Applicants:
KATHOLIEKE UNIVERSITEIT LEUVEN, KU LEUVEN R&D, IMEC VZW
Inventors:
Hans Goverde, Francky Catthoor, Vikas Dubey, Jef Poortmans
Abstract: A first device for a system for connecting a blade to an arm of a windscreen wiper is disclosed. The first device includes means of articulation configured to interact with complementary means of a second device of the connecting system, in order to define an axis of articulation of the first device in relation to the second device, which is an axis of articulation of the blade in relation to the arm. The first device includes first means of abutment configured to interact with the second device to maintain the first device in relation to the second device in translational movement in the axis of articulation, in a first direction, and second means of abutment configured to interact with the second device to maintain the first device in relation to the second device in translational movement in the axis of articulation, in a second direction counter to the first direction.
Abstract: A damper assembly is provided with a cylinder (10) having a piston assembly (14) mounted for reciprocal movement therein. The piston assembly (14) divides the cylinder (10) into separate chambers with a restricted flow path therebetween for passage of damping fluid contained within the cylinder. The restricted flow path is defined between elements whose shape and/or relative position is designed to vary with temperature.
Type:
Application
Filed:
April 28, 2014
Publication date:
March 17, 2016
Applicant:
Lama D. D. Dekani
Inventors:
Valter Svara, Danijel Kozlovic, David Pecar
Abstract: The invention pertains to a tintable hard coat composition for forming a film on an optical article, the composition comprising at least one tinting enhancer, and at least two polymerizable monomers, a first monomer being an hydrolysat of an alkoxysilane comprising at least two alkoxy groups and one epoxy group, and a second monomer having at least two functional groups reacting with the first monomer, at least one of the two monomers having three functional groups of the same kind; the tinting enhancer being preferably chosen from the group consisting of 4-(methyl mercapto) phenol, 4,4? thiodiphenol,4,4?-Sulfonyldiphenol, and 3,3?-(Ethylenedioxy)diphenol or a mix thereof: Formulas (I), (II), (III), (IV).
Type:
Application
Filed:
April 29, 2014
Publication date:
March 17, 2016
Applicant:
ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE)
Abstract: A method for producing an ophthalmic lens comprised of a base lens and a film structure bound to said base lens includes a pressure-free heating. Said heating is performed after assembling the film structure with a semi-finished lens (1), and before said semi-finished lens is machined for obtaining the base lens. Although a maximum heating temperature is higher than a glass-transition temperature of the semi-finished lens, no image distortion and optical aberration is produced for the final ophthalmic lens. The maximum heating temperature is also lower than a glass-transition temperature of the film structure.
Type:
Grant
Filed:
December 8, 2010
Date of Patent:
March 15, 2016
Assignee:
Essilor International (Compagnie Generale D'Optique)
Abstract: Disclosed are a method of forming a back reflection layer in a solar cell, a composition used therefor, and a solar cell having a back reflection layer formed by the method, which layer has superior heat-resistance and various types of durabilities, and can contribute to improving the conversion rate of solar cells and reliability during long-term use, and which method can form a back reflection layer in a solar cell easily and at low cost. The polyimide resin composition for use in forming a back reflection layer in a solar cell includes an organic solvent, a polyimide resin dissolved in the organic solvent, and light-reflecting particles dispersed in the organic solvent.
Abstract: Optical patches are assigned to prescriptions so as to reduce the total number of patch surfaces which are involved. The prescriptions are produced by varying at least one of a front patch surface (S1) and rear patch surface (S2) which are combined to form an optical patch, in accordance with prescription segments. The front patch surfaces (S1) are pseudo-spherical and the rear patch surfaces (S2) include a Fresnel structure superimposed on a pseudo-spherical base shape.
Type:
Grant
Filed:
September 6, 2011
Date of Patent:
March 15, 2016
Assignee:
ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE)
Abstract: To prevent measurement errors caused by impact including an impact load transmitted at high speed or static electricity and prevent destruction of a sensor unit due to the above-mentioned impact load. Through-holes (12f) are formed in four corners of a pan receiver, upwardly protruding pieces (14a) of a plate spring fixed to a bottom surface of the pan receiver are inserted into the through-holes (12f), and pan receiver legs are attached to the upwardly protruding pieces (14a).
Abstract: A method for an observational screening method or a drug screening method, includes the steps of providing an enclosure for at least one animal with outer sidewalls, preferably 4 outer sidewalls; providing temperature sensing device for sensing a body temperature of at least one animal and/or activity measurement device for measuring at least one parameter related to physical activity of at least one animal; sensing a body temperature of at least one animal and/or measuring at least one parameter related to physical activity of at least one animal; providing data processing device; and processing data related to body temperature and/or to the parameter related to physical activity.
Abstract: The present invention relates to a fused refractory product having the following average chemical composition, as a percentage by weight on the basis of the oxides and for a total of 100%: ZrO2: 60.0%-80.0%; SiO2: 4.0%-10.0%; Al2O3: balance to 100%; Y2O3?5.0%; Na2O+K2O+B2O3?0.3% and SiO2/(Na2O+K2O+B2O3)?5.0; other oxide species: ?2.0%; the ratio of the ZrO2/Al2O3 weight contents being between 2.0 and 6.0.
Type:
Grant
Filed:
July 16, 2012
Date of Patent:
March 15, 2016
Assignee:
SAINT-GOBAIN CENTRE DE RECHERCHES ET D'ETUDES EUROPEEN
Abstract: A device (10) for determining a group of at least one vision aid apparatus suitable for the vision of an individual, includes computing elements programmed to: a) determine at least one characteristic of the vision of the individual, b) determine at least one use of the group of at least one vision aid apparatus, desired by the individual, c) determine the group of at least one vision aid apparatus as a function of the characteristic of the vision and of the use desired by the individual.
Type:
Grant
Filed:
August 9, 2011
Date of Patent:
March 15, 2016
Assignee:
ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE)
Abstract: Apparatus, methods, and computer-readable media are provided for segmentation, processing (e.g., preprocessing and/or postprocessing), and/or feature extraction from tissue images such as, for example, images of nuclei and/or cytoplasm. Tissue images processed by various embodiments described herein may be generated by Hematoxylin and Eosin (H&E) staining, immunofluorescence (IF) detection, immunohistochemistry (IHC), similar and/or related staining processes, and/or other processes. Predictive features described herein may be provided for use in, for example, one or more predictive models for treating, diagnosing, and/or predicting the occurrence (e.g., recurrence) of one or more medical conditions such as, for example, cancer or other types of disease.
Type:
Grant
Filed:
January 30, 2013
Date of Patent:
March 15, 2016
Assignee:
FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD
Inventors:
Peter Ajemba, Richard Scott, Janakiramanan Ramachandran, Jack Zeineh, Michael Donovan, Gerardo Fernandez, Qiuhua Liu, Faisal Khan
Abstract: This invention provides compounds of formula I: wherein a, b, c, d, m, n, p, s, t, W, Ar1, R1, R2, R3, R4, R6, R7, and R8 are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.
Type:
Grant
Filed:
November 12, 2014
Date of Patent:
March 15, 2016
Assignee:
Theravance Biopharma R&D IP, LLC
Inventors:
Mathai Mammen, YuHua Ji, YongQi Mu, Craig Husfeld, Li Li
Abstract: A method of preparing a transparent polymer material includes mixing mineral nanoparticles selected from nanoparticles of alkaline-earth metal carbonates, alkaline-earth metal sulfates, metallic oxides, oxides of metalloids, and siloxanes, and a composition A including at least one thermoplastic polymer in the molten state selected from polycarbonate (PC), polystyrene (PS) and polymethyl methacrylate (PMMA) in order to obtain a master-batch, the mixture of step i) including at least 25% and at most 75% by weight of the mineral nanoparticles. The master-batch obtained in step i) is mixed with a composition B of a thermoplastic polycarbonate matrix (PCm) in the molten state, to obtain a transparent polymer material including at most 10% by weight of the mineral nanoparticles, preferably at most 5% by weight of the mineral nanoparticles.
Type:
Grant
Filed:
December 9, 2008
Date of Patent:
March 15, 2016
Assignees:
ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE), RENAULT S.A.S.; SOLVAY SA
Inventors:
Virginie Boucher, Alexandra Roos, Sophie Duquesne, Serge Bourbigot, Laure Meynie, Karine Cavalier, Didier Sy, Marc Lacroix
Abstract: This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterized by cytotoxic ?-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds. The compounds have the formula (A1), wherein R1, R2, R4, R5, R6, E, n, Y1, Y2, Y3, Y4, Y5, B, R8, and m are as defined in the claims.